wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34974335-22A1CE19-9FA0-4289-B548-AF4C6E3DA3D2
Q34974335-22A1CE19-9FA0-4289-B548-AF4C6E3DA3D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34974335-22A1CE19-9FA0-4289-B548-AF4C6E3DA3D2
Tumor necrosis factor inhibitors - state of knowledge.
P2860
Q34974335-22A1CE19-9FA0-4289-B548-AF4C6E3DA3D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34974335-22A1CE19-9FA0-4289-B548-AF4C6E3DA3D2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
199d98b51576088e95dc0092fa522d0aae5c9b34
P2860
Infliximab for diabetic macular edema refractory to laser photocoagulation: a randomized, double-blind, placebo-controlled, crossover, 32-week study.